KSchultz

[HealthTree Foundation @HealthTree]

Today, the FDA approved ziftomenib (Komzifti), the first once-daily targeted therapy for adults with relapsed or refractory AML with NPM1 mutations.
This marks an important advancement for the ~1 in 3 patients who often face limited options.
As a menin inhibitor, it helps restore healthy blood cell development, offering a new treatment pathway.
Read the full article here: https://t.co/LtyDlllSeB

#AML

[Kura Oncology @kuraoncology]

#NEWS: U.S. FDA grants full approval of our menin inhibitor for adults with relapsed/refractory NPM1-mutant #AML. Learn how this targeted therapy marks an important shift towards precision treatment. https://t.co/13WKEp1Tik

[KSchultz @klmmanhattan]

@GovAbbottPress Would be great if the Apply Texas site actually worked. Students can’t get past step 1! It freezes when answering YES to are you a citizen. Please fix your APPLY TEXAS site to actually help students in Texas @ApplyTexas

[KSchultz @klmmanhattan]

@ApplyTexas please fix your website! It’s not allowing students to apply since they can’t get past step 1 and answer YES to, Are You a citizen. Please fix.

[Know AML 🔴⚫️ @KNOW_AML]

🎥 Dr Harry Erba @DukeCancer discusses NPM1 mutations in acute myeloid leukemia and current ongoing research into the treatment of NPM1-mutated acute myeloid leukemia.

Watch the full video here: https://t.co/AsLUtbcNn7

#AMLsm #leusm #MedEd

[Kura Oncology @kuraoncology]

#TeamKura stands together in support of those impacted by #AML. On #WorldAMLAwarenessDay, we reaffirmed our commitment to patients—advancing research, supporting advocacy, and working toward better outcomes.

Learn more: https://t.co/4UwivaaBbZ

[Kura Oncology @kuraoncology]

#TeamKura is proud to stand alongside the @LLSusa for another great annual #LightTheNightSanDiego event! The dedication and support embody our shared mission of advancing research and advocacy for cancer patients everywhere. See photos from the event below:

[Kura Oncology @kuraoncology]

Thank you #TeamKura and @LLSusa for another great annual Light the Night Boston event! We’re proud to participate in this honorable initiative that aims to bring light to the darkness of cancer. See the booth we supported and photos from the event below:

#LightTheNightBoston

[KSchultz @klmmanhattan]

Exciting news! Follow us!

[AbbVie Oncology Medical Affairs @AbbVieUSOncMed]

Welcome to @AbbVieUSMedOnc!

Follow us as we share updates on @AbbVie peer-reviewed publications, trials in progress and scientific presentations with the US Hematology/Oncology community. This channel is intended for US #HCPs only. [1/3]

[KSchultz @klmmanhattan]

@MyelomaTeacher @IMFjimMYELOMA Jim’s cap and the station are ironic given the timing of the MLB Series! ⚾️ Astros vs. Yankees. Sounds like a fun meeting in NYC!

[KSchultz @klmmanhattan]

@IMFjimMYELOMA HAPPY BIRTHDAY JIM!!! Thanks for all you do to make a positive impact on others!

[KSchultz @klmmanhattan]

The great coverage from ASH 2021 continues. $kpti

[International Myeloma Foundation @IMFmyeloma]

Clinical Outcomes in Patients with Dose Reduction of Selinexor in Combination with Bortezomib, and Dexamethasone (XVd) in Previously Treated Multiple Myeloma from the Boston Study https://t.co/ed7X0M4wGR

[Karyopharm @Karyopharm]

The @IMFmyeloma kicked off their M-POWER initiative in Atlanta, GA! M-POWER aims to change the course of multiple myeloma by removing barriers to early diagnosis and treatment in the African-American community.
Learn more about M-POWER here: https://t.co/PpAgHitszs

[KSchultz @klmmanhattan]

It’s Gynecologic Cancer Awareness month and we had so much fun participating in the #Foundationforwomenscancer virtual #Move4Her event to help raise crucial funds for awareness, education, outreach and research of gynecologic cancers. #Move4Her $kpti #karyopharm

[Ana Alarcon Tomas @AnaAlarconTomas]

"Work somewhere where people are kind, have good work-ethic, support and respect each other, are hardworking, value you"Great advice from an outstanding BMT faculty at @WeillCornell and my #bestie too @AGomez_MD. Talks by @ASTCT "Early career Job search in transplant/Cell thrapy"

[The Patient Story @Patient_Story]

❌Learning treatment options often feels like swimming through alphabet soup.
✅Dr. Baljevic + Dr. Patel were gracious enough to lend their expertise for us on #myeloma👇

https://t.co/L2nNUCDjHm

#mmsm #clinicaltrials #CARTcell #bispecifics #xpovio #pepaxto #sarclisa #blenrep

[KSchultz @klmmanhattan]

@GregAbbott_TX TX Homicide rate up 42% from 2020. Children and teachers dying of COVID after your no mask mandate. How are broadened gun laws and restricting women’s rights your priorities.

[International Myeloma Foundation @IMFmyeloma]

Hot Off the Press: New Myeloma Today Edition Presents Highlights of the IMWG Summit, ASCO & EHA Annual Meetings, and Other Updates https://t.co/T9cBBfgQFL

[KSchultz @klmmanhattan]

Selinexor With Backbone Therapy for Triple-Class Refractory Multiple Myeloma https://t.co/oTwgHv3vqi via @onclive